William Blair on Neurogene (NGNE): dosing update further de-risks NGN-401 profile Mar 24, 2026 10:50AM
Neurogene (NGNE) Announces Oversubscribed $200 Million Private Placement Nov 4, 2024 07:32AM
Neurogene Announces Oversubscribed $200 Million Private Placement Nov 4, 2024 07:30AM
William Blair Starts Neurogene (NGNE) at Outperform, 'The Goldilocks of Gene Therapy' Mar 21, 2024 07:34AM